NanoVibronix's EBIT per Share for the
three
months ended in Dec. 2023 was $-0.39.
Its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $-2.05.
During the past 3 years, the average EBIT per Share Growth Rate was 40.20% per year.
During the past 5 years, the average EBIT per Share Growth Rate was 34.10% per year.
During the past 10 years, the average EBIT per Share Growth Rate was 11.10% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for NanoVibronix's EBIT per Share or its related term are showing as below:
NAOV'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -21.1 Med: -8.3 Max: 40.2
Current: 40.2
During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of NanoVibronix was 40.20% per year. The lowest was -21.10% per year. And the median was -8.30% per year.
NAOV's 3-Year EBIT Growth Rate is ranked better than 85.85% of 721
companies
in the Medical Devices & Instruments industry
Industry Median: 6.7
vs NAOV: 40.20
NanoVibronix's EBIT for the
three
months ended in Dec. 2023 was $-0.77 Mil.
NanoVibronix EBIT per Share Historical Data
The historical data trend for NanoVibronix's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-2.05
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NanoVibronix (NAS:NAOV) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
NanoVibronix EBIT per Share Related Terms
Thank you for viewing the detailed overview of NanoVibronix's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.
NanoVibronix Inc manufactures noninvasive biological response-activating devices that target biofilm prevention, pain therapy, and wound healing and can be administered at home, without the assistance of medical professionals. Its primary products are UroShield; PainShield; and WoundShield. Each of its UroShield, PainShield, and WoundShield products employs a small, disposable transducer that transmits low frequency, low intensity ultrasound acoustic waves that seek to repair and regenerate tissue, musculoskeletal and vascular structures, and decrease biofilm formation on urinary catheters and associated urinary tract infections. The company derives revenues from selling its products directly to patients as well as through distributor agreements.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
NAOV has been successfully added to your 